博深股份(002282) - 2022 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2022 was ¥344,882,373.10, a decrease of 10.57% compared to ¥385,660,148.03 in the same period last year[3] - Net profit attributable to shareholders was ¥20,364,241.49, down 64.94% from ¥58,083,367.81 year-on-year[3] - Basic earnings per share decreased by 63.64% to ¥0.04 from ¥0.11 in the same period last year[3] - Net profit for the current period is ¥21,266,758.95, down 63.7% from ¥58,639,439.12 in the previous period[19] - Operating profit decreased to ¥24,496,677.36, a decline of 67.2% compared to ¥74,634,986.53 in the previous period[19] - Other comprehensive income after tax for the current period is -¥14,960,087.61, compared to ¥85,204,275.80 in the previous period[19] Cash Flow and Liquidity - The net cash flow from operating activities was -¥19,448,789.26, a decline of 169.46% compared to ¥28,000,118.02 in the previous year[3] - Cash flow from operating activities showed a net outflow of ¥19,448,789.26, contrasting with a net inflow of ¥28,000,118.02 in the previous period[23] - Cash and cash equivalents decreased by 104.08% to -¥14,452,718.90, mainly due to reduced cash inflow from sales[8] - Cash and cash equivalents at the end of the period totaled ¥363,245,442.57, a decrease from ¥518,573,820.25 at the end of the previous period[23] Assets and Liabilities - The total assets at the end of the reporting period were ¥3,840,990,882.49, a slight decrease of 0.99% from ¥3,879,366,273.55 at the end of the previous year[3] - Total current assets amount to 1,497,802,400.87 CNY, a slight decrease from 1,508,932,918.32 CNY at the beginning of the year[14] - Total liabilities decreased to 430,907,586.22 CNY from 475,589,648.64 CNY, a reduction of approximately 9.4%[15] - Non-current liabilities decreased to 82,995,053.51 CNY from 89,004,998.48 CNY, a decline of about 6.5%[15] - The total equity attributable to the parent company is 3,377,987,759.63 CNY, slightly up from 3,372,583,605.73 CNY[16] Operational Challenges - The company experienced a significant decline in net profit due to a production halt caused by pandemic control measures, resulting in a revenue drop of approximately ¥40 million from its subsidiary[7] - Financial expenses increased by 135.22% to ¥2,147,651.59, primarily due to exchange rate losses[7] - The company reported a decrease in investment income by 35.74% to ¥174,364.28, attributed to reduced bank wealth management returns[7] - Total operating costs increased to ¥320,925,216.64, up 1.5% from ¥315,982,999.01 in the previous period[18] Shareholder Information - Total number of common shareholders at the end of the reporting period is 18,062[10] - The largest shareholder, Chen Huairong, holds 9.43% of shares, amounting to 51,316,818 shares, with 38,487,613 shares pledged[10] Research and Development - The company reported a significant increase in R&D expenses to ¥16,378,348.82, up 12.4% from ¥14,575,608.10 in the previous period[18] Inventory and Receivables - Accounts receivable increased to 403,540,683.82 CNY from 340,284,316.48 CNY, reflecting a growth of approximately 18.6%[14] - Inventory stands at 505,901,172.53 CNY, up from 498,198,857.49 CNY, indicating a growth of about 1.4%[14]